You missed my point. It has nothing to do with the naysayers. It has to do with what the CEO stated prior to the reverse split. I believe he was answering an analysts question about milestones and material events that he thought would help the stock prior to the uplisting. It obviously didn't per the fact that stock has cratered since the RS. I hope that something material happens soon to reverse what we are all now experiencing.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links